Definitive Contract 75A50121C00030
Award Date
3/25/21
Potential Completion Date
10/31/23
Potential Value
$750K
Awardee
Xequel Bio, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mt Pleasant, SC 29464, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Esperovax Inc. a $484,643 firm fixed price definitive contract to develop host-directed therapeutic candidates for mitigating long-term effects of respiratory distress. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought proposals for candidates aiding long-term outcomes from lung injury through Area of...
This is a definitive cost-plus-fixed-fee contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Physical Sciences Inc., a for-profit research and development company. The contract was awarded under FDA Broad Agency Announcement BAA-18-00123, titled "Single Vial Mass Flow Rate Sensor Assessment of Freeze Drying Heterogeneity", with Proposal Number PMQWP#195. The contract has a potential value of $959,248.00 and a completion date of December...
This federal contract award, W81XWH17C0065, was issued by the Defense Health Agency (DHA) to Xequel Bio, Inc., a for-profit small business, under the SBIR (Small Business Innovation Research) Program Phase II. The $999,960.15 cost-reimbursement contract supports Xequel Bio's research and development of innovative biomedical solutions, including therapies for infectious disease, medical countermeasures, regenerative medicine, and battlefield medicine. Xequel Bio has been awarded several...
This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...
This federal contract award, valued at $330,136,246.14, was granted by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to 4J Therapeutics Inc., a self-certified small disadvantaged business. The contract's objective is to demonstrate the versatility and efficacy of 4J Therapeutics' programmable antiviral technology platform by assembling a preclinical package for LNA14, performing a Phase 1a...
This is a $749,999.01 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Red Queen Therapeutics Inc., a self-certified small disadvantaged business. The contract is for research and development of a rapid response platform for the development of a pan-influenza virus fusion inhibitor for the treatment of influenza virus infections. This contract is not set aside and has an ultimate completion date of...
This is a $65,806,649.98 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Biofactura Inc., a for-profit manufacturer located in Frederick, Maryland. The contract includes preclinical and manufacturing development activities such as cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract has an...
This contract was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Meso Scale Diagnostics LLC, a small business provider of assay development, testing equipment, and immunoassays. The contract, valued at $23,234,896, is for the acquisition of assays to support COVID-19 vaccine development efforts, in response to a Broad Agency Announcement (BAA) issued by the agency. The contract is a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Full Spectrum Group LLC, doing business as FSA, a for-profit organization, for preventative maintenance services on Agilent 1100 HPLC 1946 single quadrupole mass selective detector (LC-MS) and Agilent 1290 Infinity UPLC with 6460C triple quadrupole mass selective detector (LC-QqQ) laboratory equipment. The contract...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...